Study performed at the Department of Dermatology, 12 de Octubre University Hospital, Madrid, Spain.

For decades, unfractionated heparin (hereafter, heparin) has been the primary anticoagulant used for extracorporeal membrane oxygenation (ECMO) support. More recently, however, bivalirudin, a direct ...

The HELP-PCI trial evaluated the impact of early administration of unfractionated heparin in patients with STEMI. The trial showed that early heparin administration improved myocardial blood flow but ...

Objective and Design: Tinzaparin and dalteparin are low molecular weight heparins (LMWHs) with different pharmacokinetic and pharmacodynamic profiles that may lead to differences in efficacy and ...

Pretreatment of STEMI patients with a loading-dose of unfractionated heparin (UFH) at first medical contact (FMC) vs. in the catheterization lab (cathlab) was associated with improved spontaneous ...

Background: This study aimed to investigate whether early unfractionated heparin (UFH) administration provides a survival advantage for patients with sepsis-induced coagulopathy (SIC). Methods: ...

Currently approved anticoagulants for treatment of patients with coronary artery disease manifestations include unfractionated heparin, low-molecular-weight heparins, bivalirudin, and fondaparinux.